Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Haller

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Phase I and pharmacokinetic trial of the novel taxane BMS-184476 administered as a 1-hour intravenous infusion in combination with cisplatin every 21 daysWeijing Sun, James P Stevenson, Maryann L Gallagher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data setMichael J O'Connell, Megan E Campbell, Richard M Goldberg, et al.
Annals of Internal Medicine|October 22, 2003
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrenceJeffrey A Meyerhardt, Paul J Catalano, Deborah Schrag, et al.
Clinical Colorectal Cancer|March 29, 2021
Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 PatientsOfer Margalit, Ben Boursi, Manel Rakez, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 Patterns of Care StudyMohan Suntharalingam, Jennifer Moughan, Lawrence R Coia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancerElizabeth A Poplin, Jacqueline K Benedetti, Norman C Estes, et al.
Cancer|November 30, 2006
Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II studyHeinz-Joseph Lenz, Fa-Chyi Lee, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagusMohan Suntharalingam, Jennifer Moughan, Lawrence R Coia, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2004
Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignanciesJoshua H Bilenker, James P Stevenson, Keith T Flaherty, et al.
Expert Review of Anticancer Therapy|February 27, 2018
Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisMonica Tang, Timothy Jay Price, Jeremy Shapiro, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Phase I and pharmacokinetic trial of the novel taxane BMS-184476 administered as a 1-hour intravenous infusion in combination with cisplatin every 21 daysWeijing Sun, James P Stevenson, Maryann L Gallagher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data setMichael J O'Connell, Megan E Campbell, Richard M Goldberg, et al.
Annals of Internal Medicine|October 22, 2003
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrenceJeffrey A Meyerhardt, Paul J Catalano, Deborah Schrag, et al.
Clinical Colorectal Cancer|March 29, 2021
Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 PatientsOfer Margalit, Ben Boursi, Manel Rakez, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 Patterns of Care StudyMohan Suntharalingam, Jennifer Moughan, Lawrence R Coia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancerElizabeth A Poplin, Jacqueline K Benedetti, Norman C Estes, et al.
Cancer|November 30, 2006
Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II studyHeinz-Joseph Lenz, Fa-Chyi Lee, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagusMohan Suntharalingam, Jennifer Moughan, Lawrence R Coia, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2004
Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignanciesJoshua H Bilenker, James P Stevenson, Keith T Flaherty, et al.
Expert Review of Anticancer Therapy|February 27, 2018
Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisMonica Tang, Timothy Jay Price, Jeremy Shapiro, et al.
Pageof 12